InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

HALOZYME THERAPEUTICS, INC.

HALO Clue Score50
United States Fiscal year ends December CIK 0001159036 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Helen Torley
8 Oct 2026
President and CEO
Sold after exercise
200
$110.51
$22.10K
Helen Torley
8 Oct 2026
President and CEO
Sold after exercise
11,900
$110.00
$1.31M
Helen Torley
8 Oct 2026
President and CEO
Sold after exercise
3,090
$108.91
$336.53K
Helen Torley
8 Oct 2026
President and CEO
Sold after exercise
4,810
$108.18
$520.34K
Helen Torley
7 Oct 2026
President and CEO
Sold after exercise
200
$113.69
$22.74K
Helen Torley
7 Oct 2026
President and CEO
Sold after exercise
900
$112.78
$101.50K
Helen Torley
7 Oct 2026
President and CEO
Sold after exercise
10,300
$111.84
$1.15M
Helen Torley
7 Oct 2026
President and CEO
Sold after exercise
8,600
$111.03
$954.87K
Show all 8 transactions →

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 8
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 40,000
History held since 6 Dec 2006